Diabetes and Covid-19
Reviews | No. 49 (2021)
Reviews | No. 49 (2021)

Diabetes and Covid-19

DOI: 10.47122/vjde.2021.49.2
10.47122/vjde.2021.49.2
Published 2022-02-10
Duc Hoang Nguyen
Hue Central Hospital
Huu Dang Tran
Hue University of Medicine and Pharmacy
PDF (Tiếng Việt)

Keywords

BMI
COVID-19
Đái tháo đường
ICU BMI
COVID-19
diabetes
ICU

Working Languages

Tiếng Việt

How to Cite

Nguyễn, Đức H., & Trần, H. D. (2022). Diabetes and Covid-19. Vietnam Journal of Diabetes and Endocrinology, (49), 16-24. https://doi.org/10.47122/vjde.2021.49.2
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Patients with diabetes are one of the risk factors for not only increased sepsis but also rapid progression and severe prognosis of COVID-19. Therefore, patients with diabetes need to be closely monitored, the importance of  glycosylation, viral  protein mutations and ACE2r. Better glycemic control is required in patients with hyperglycemia on admission. Pre-diabetes and diabetes are potential mechanisms for slowing the spread of COVID-19 and reducing symptoms and improving treatment outcomes. We know that glycemic control is essential for COVID-19 patients and even patients without COVID-19. However, hyperglycemia remains a strong prognostic factor for the prognosis of hospitalized COVID-19 patients.

https://doi.org/10.47122/vjde.2021.49.2
PDF (Tiếng Việt)

Most read articles by the same author(s)

1 2 > >>